These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34075400)

  • 21. Telemedicine During the COVID-19 Crisis and Beyond.
    Blevins T; Ozer K
    Tex Med; 2020 Jul; 116(7):4-5. PubMed ID: 32872703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea.
    Kim MK; Jeon JH; Kim SW; Moon JS; Cho NH; Han E; You JH; Lee JY; Hyun M; Park JS; Kwon YS; Choi YK; Kwon KT; Lee SY; Jeon EJ; Kim JW; Hong HL; Kwon HH; Jung CY; Lee YY; Ha E; Chung SM; Hur J; Ahn JH; Kim NY; Kim SW; Chang HH; Lee YH; Lee J; Park KG; Kim HA; Lee JH
    Diabetes Metab J; 2020 Aug; 44(4):602-613. PubMed ID: 32794386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in Diabetes Care during the COVID-19 Outbreak in Japan: an Observational Study.
    Ikesu R; Miyawaki A; Sugiyama T; Nakamura M; Ninomiya H; Kobayashi Y
    J Gen Intern Med; 2021 May; 36(5):1460-1462. PubMed ID: 33469742
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of COVID-19 on Health Economics and Technology of Diabetes Care: Use Cases of Real-Time Continuous Glucose Monitoring to Transform Health Care During a Global Pandemic.
    Garg S; Norman GJ
    Diabetes Technol Ther; 2021 Mar; 23(S1):S15-S20. PubMed ID: 33449822
    [No Abstract]   [Full Text] [Related]  

  • 25. A roadmap to recovery: ABCD recommendations on risk stratification of adult patients with diabetes in the post-COVID-19 era.
    Choudhary P; Wilmot EG; Owen K; Patel DC; Mills L; Rayman G; Winocour P; Ayman G; Patel R; Hambling C; Nagi DK
    Diabet Med; 2021 Mar; 38(3):e14462. PubMed ID: 33230813
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter to the Editor regarding 'COVID-19 and diabetes: What does the clinician need to know?'.
    Abbasi-Oshaghi E; Mirzaei F; Khodadadi I
    Prim Care Diabetes; 2021 Feb; 15(1):30. PubMed ID: 33162350
    [No Abstract]   [Full Text] [Related]  

  • 27. COVID-19 pandemic, coronaviruses, and diabetes mellitus.
    Muniyappa R; Gubbi S
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E736-E741. PubMed ID: 32228322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 and diabetes: A bidirectional relationship.
    Lima-Martínez MM; Carrera Boada C; Madera-Silva MD; Marín W; Contreras M
    Clin Investig Arterioscler; 2021; 33(3):151-157. PubMed ID: 33303218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence.
    Tamuzi JL; Ayele BT; Shumba CS; Adetokunboh OO; Uwimana-Nicol J; Haile ZT; Inugu J; Nyasulu PS
    BMC Infect Dis; 2020 Oct; 20(1):744. PubMed ID: 33036570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 and diabetes: Covidiabetology.
    Kalra S; Mittal S
    J Pak Med Assoc; 2020 Jun; 70(6):954-955. PubMed ID: 32810084
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review.
    Singh AK; Khunti K
    Diabetes Res Clin Pract; 2020 Jul; 165():108266. PubMed ID: 32533989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 and diabetes mellitus: implications for prognosis and clinical management.
    Barber TM
    Expert Rev Endocrinol Metab; 2020 Jul; 15(4):227-236. PubMed ID: 32511033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.
    Singh AK; Singh R
    Diabetes Res Clin Pract; 2020 Sep; 167():108382. PubMed ID: 32853686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
    Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
    Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes, like COVID-19, is a wicked problem.
    Kerr D; Glantz N
    Lancet Diabetes Endocrinol; 2020 Nov; 8(11):873-874. PubMed ID: 33010821
    [No Abstract]   [Full Text] [Related]  

  • 37. Environmental pollution and COVID-19: the molecular terms and predominant disease outcomes of their sweetheart agreement.
    Colacci A; Bortone G; Maffei G; Marchesi S; Mescoli A; Parmagnani F; Pillo G; Ranzi A; Rotondo F; Serra S; Vaccari M; Zauli Sajani S; Mascolo MG; Jacobs MN
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):169-182. PubMed ID: 33412808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Does having diabetes increase chances of contracting COVID-19 infection?".
    Gangopadhyay KK
    Diabetes Metab Syndr; 2020; 14(5):765-766. PubMed ID: 32512520
    [No Abstract]   [Full Text] [Related]  

  • 39. How diabetes management is adapting amid the COVID-19 pandemic.
    Ranscombe P
    Lancet Diabetes Endocrinol; 2020 Jul; 8(7):571. PubMed ID: 32422126
    [No Abstract]   [Full Text] [Related]  

  • 40. The Time of Uncertainty in Poland.
    Dzida GJ
    J Diabetes Sci Technol; 2020 Jul; 14(4):731-732. PubMed ID: 32460551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.